PreComb Therapeutics

Private

HombrechtikonHealthcare & Life Scienceshttps://www.precomb.com/

Last Round

Series A

Dec 30, 2024

Total Funding Raised

$3.73M

Company Overview

PreComb Therapeutics is a biotechnology company that develops 3D microtumor-based drug testing platforms to enable personalized cancer therapy and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

precision oncology3D tumor modelspersonalized medicinedrug discoverydrug screeningfunctional drug testinghigh-throughput screeningorganoid technologypatient-derived modelsAI-driven drug discoverytherapy guidancepredictive oncologyautomated lab equipmentcancer research toolslab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PreComb Therapeutics Comparables

Compare PreComb Therapeutics with similar companies based on industry and business-model similarity.

PreComb Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
2cureX	83%
First Ascent Biomedical	82%
Kiyatec	81%

View all Comparables

PreComb Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 30, 2024
Seed	Oct 4, 2022
Seed	Apr 28, 2021

View all Funding Rounds

PreComb Therapeutics Investors

Notable investors and investment history

PreComb Therapeutics investors
Investor	Rounds
Koodos	Series A
LongeVC	Seed
Kinled Holding	Seed
High-Tech Gründerfonds	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 1, 2026
Monthly visitors grew 124% MoM, reaching 1.7K.
Oct 30, 2024
Monthly visitors increased 103% MoM.

View all signals

PreComb Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PreComb Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PreComb Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHombrechtikon

Employee Range12

Year Founded2018

Last FundingDec 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.